Founded in 2000, Hatteras Venture Partners invests in seed and early stage companies with a focus on biopharmaceuticals, medical devices, diagnostics, healthcare IT, and related opportunities in human medicine. The firm will typically invest in companies located in the research-driven, capitally-underserved regions of North Carolina and the Southeastern United States. Core to the mission of Hatteras Venture Partners is a belief that entrepreneurial innovation will create valuable new products that will transform the practice of medicine and create value for our investors. As entrepreneurs, operators, and investors, we are dedicated to the success of our portfolio companies and to the men and women who create them. Based in Durham, NC, the firm has four funds and over $250 million under management.
Hatteras Venture Partners
Venture CapitalFounded in 2000, Hatteras Venture Partners invests in seed and early stage companies with a focus on biopharmaceuticals, medical devices, diagnostics, healthcare IT, and related opportunities in human medicine.
84
Total Investments
49
Portfolio Companies
-
Exits
1
Industries
General Information
Company Overview
Investment Criteria
•••••• •••••• ••••••
About Hatteras Venture Partners
Recent Investments (84)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series B | •••••• | Apr 2026 | |
| Series C | •••••• | Apr 2025 | |
| Series C | •••••• | Jun 2024 | |
| Series C | •••••• | Apr 2024 | |
| Venture Round | •••••• | Jun 2023 | |
|
|
Series B | •••••• | May 2023 |
|
|
Series A | •••••• | May 2023 |
|
|
Series A | •••••• | May 2023 |
|
|
Series A | •••••• | Apr 2023 |
|
|
Series A | •••••• | Apr 2023 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.